A Podcast on Patient and Physician Perspectives on the Management of Endometriosis and Relugolix Combination Therapy

IF 3.4 3区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Advances in Therapy Pub Date : 2024-10-19 DOI:10.1007/s12325-024-02970-2

Tara Mangum, Sanjay K. Agarwal

引用次数: 0

Abstract

Endometriosis is a common disease, affecting approximately 5–10% of reproductively aged women. Symptoms, such as painful periods, negatively impact an individual’s quality of life; however, these symptoms are often normalized, leading to delays in diagnosis and treatment, and worsening of the disease. In this podcast, a reproductive endocrinologist (Dr Sanjay K Agarwal) and patient advocate (Tara Mangum) provide their perspectives on the diagnosis and management of endometriosis. They also discuss Relugolix combination therapy as a treatment option for patients with endometriosis.

Podcast available for this article.

查看原文本刊更多论文

关于患者和医生对子宫内膜异位症治疗和瑞乐高联合疗法的看法的播客。

子宫内膜异位症是一种常见疾病，约有 5-10%的育龄妇女患有此病。痛经等症状会对个人的生活质量产生负面影响；然而，这些症状往往被正常化，导致诊断和治疗的延误以及疾病的恶化。在本期播客中，生殖内分泌专家（Sanjay K Agarwal 博士）和患者权益倡导者（Tara Mangum）就子宫内膜异位症的诊断和治疗发表了自己的观点。他们还讨论了作为子宫内膜异位症患者治疗选择的瑞乐高联合疗法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Therapy 医学-药学

CiteScore

7.20

自引率

2.60%

发文量

353

审稿时长

6-12 weeks

期刊介绍： Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.